NCT05922540Recruiting
a Cohort Study of Ischemic Cerebrovascular Disease
a Prospective, Multicenter Cohort Study of Ischemic Cerebrovascular Disease
Source: ClinicalTrials.gov · Last updated 28 Jun 2023 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This study aims to establish a multicenter, large-scale, prospective cohort of patients with ischemic stroke. Various biological samples such as blood, feces, and urine are collected to identify biomarkers associated with ischemic stroke. By integrating demographic information, clinical indicators, imaging parameters, and biomarker parameters, the study aims to develop risk assessment, early warning, and prognosis prediction models. Additionally, the study aims to identify key genes and explore relevant signaling pathways related to ischemic stroke.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 5000 (estimated)
- First submitted
- 19 Jun 2023
- Start date
- 1 Nov 2022
- Primary completion date
- 1 Nov 2026
- Lead sponsor
- Xiangya Hospital of Central South University
- Diseases
- Stroke
- NCT number
- NCT05922540
What you commit to
- Study type: Observational
- Planned participants: 5000
- From 1 Nov 2022 to the primary completion date, 1 Nov 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients with concurrent malignant tumors or severe systemic diseases with an expected survival period of less than 90 days.
- Patients who have participated in other clinical studies within 30 days prior to enrollment or are currently participating in other interventional clinical studies.
Other illness
- Patients with moderate to severe mental disorders or dementia who cannot cooperate to complete the informed consent and follow-up procedures.
- Patients with neurological functional impairment caused by conditions such as migraine aura, epilepsy, or other non-ischemic strokes.
Other
- Agitated patients who cannot cooperate with imaging examinations.
- Pregnant or lactating patients, as well as those planning to become pregnant within 90 days.
Who the study is looking for
- Clinical diagnosis of ischemic stroke.
- Age ≥ 18 years.
- Signed informed consent form.
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Xiangya Hospital Central South University Coordinator of this site? Confirm its status | Hunan | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.